• 1. Emerging investigator series: first-principles and thermodynamics comparison of compositionally-tuned delafossites: cation release from the (001) surface of complex metal oxides?
  Joseph W. Bennett,Diamond T. Jones,Blake G. Hudson,Joshua Melendez-Rivera,Robert J. Hamers,Sara E. Mason Environ. Sci.: Nano, 2020,7, 1642-1651
• 2. Dissociative dynamics of O2 on Ag(110)?
  Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445
• 3. Exceptionally high temperature spin crossover in amide-functionalised 2,6-bis(pyrazol-1-yl)pyridine iron(ii) complex revealed by variable temperature Raman spectroscopy and single crystal X-ray diffraction?
  Max Attwood,Hiroki Akutsu,Lee Martin,Toby J. Blundell,Pierre Le Maguere,Scott S. Turner Dalton Trans., 2021,50, 11843-11851
• 4. Fe3O4 nanoparticle chains with N-doped carbon coating: magnetotactic bacteria assisted synthesis and high-rate lithium storage?
  Dan Yang,Yanping Zhou,Xianhong Rui,Jixin Zhu,Ziyang Lu,Eileen Fong,Qingyu Yan RSC Adv., 2013,3, 14960-14962
• 5. Fast-pulsing NMR techniques for the detection of weak interactions: successful natural abundance probe of hydrogen bonds in peptides?
  Amandine Altmayer-Henzien,Valérie Declerck,David J. Aitken,Ewen Lescop,Denis Merlet,Jonathan Farjon Org. Biomol. Chem., 2013,11, 7611-7615

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Prostaglandins and related compounds
• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Eicosanoids Prostaglandins and related compounds

Professional Introduction to 4-Nor-3,5-seco-5-oxo-17β-hydroxyandrostan-3-oic Acid (CAS No. 1759-35-9)

4-Nor-3,5-seco-5-oxo-17??-hydroxyandrostan-3-oic Acid, identified by its CAS number 1759-35-9, is a significant compound in the field of biochemistry and pharmaceutical research. This compound belongs to the class of androgenic steroids, which have garnered considerable attention due to their diverse biological activities and potential therapeutic applications. The molecular structure of 4-Nor-3,5-seco-5-oxo-17β-hydroxyandrostan-3-oic Acid features a complex arrangement of functional groups, making it a valuable subject for detailed study and innovation in medicinal chemistry.

The chemical formula of this compound is C19H24O4, reflecting its composition of carbon, hydrogen, and oxygen atoms arranged in a specific configuration. The presence of hydroxyl and carboxyl groups in its structure contributes to its reactivity and interaction with biological targets. This molecular complexity has positioned 4-Nor-3,5-seco-5-oxo-17β-hydroxyandrostan-3-oic Acid as a key intermediate in the synthesis of more complex steroid derivatives, which are being explored for their pharmacological properties.

In recent years, research on steroids has seen significant advancements, particularly in understanding their role in endocrine regulation and disease mechanisms. The study of 4-Nor-3,5-seco-5-oxo-17β-hydroxyandrostan-3-oic Acid has provided insights into the structural and functional aspects of androgen receptors, which are crucial for developing treatments related to hormonal imbalances and related disorders. The compound's ability to modulate these receptors has made it a subject of interest in the development of novel therapeutics for conditions such as testosterone replacement therapy and prostate health.

The synthesis of 4-Nor-3,5-seco-5-oxo-17β-hydroxyandrostan-3-oic Acid involves multi-step organic reactions that require precise control over reaction conditions and reagent selection. Advanced synthetic methodologies have been employed to optimize yield and purity, ensuring that the final product meets the stringent standards required for pharmaceutical applications. Techniques such as chromatography and spectroscopic analysis play a crucial role in characterizing the compound's structure and verifying its identity.

One of the most compelling aspects of studying 4-Nor-3,5-seco-5-oxo-17β-hydroxyandrostan-3-oic Acid is its potential as a precursor for more complex steroid molecules. Researchers have leveraged its structural framework to develop derivatives with enhanced pharmacological activity. For instance, modifications at the 17β-hydroxyl group have been explored to improve metabolic stability and bioavailability. These efforts align with the broader goal of creating more effective and targeted therapies that minimize side effects while maximizing therapeutic benefits.

The biological activity of 4-Nor-3,5-seco-5-oxo-17β-hydroxyandrostan-3-oic Acid has been investigated in various preclinical models. Studies have demonstrated its potential role in modulating pathways associated with inflammation, metabolism, and cellular growth. These findings have prompted further exploration into its therapeutic applications, particularly in areas where hormonal regulation is a key factor. The compound's interactions with enzymes and receptors have been extensively studied to understand how it exerts its effects at the molecular level.

The latest research trends indicate that steroids like 4-Nor-3,5-seco-5-oxo-17β-hydroxyandrostan-3-oic Acid are being increasingly utilized in combination therapies to address complex diseases. The synergistic effects observed when these compounds are used alongside other pharmacological agents highlight their potential as part of multifaceted treatment strategies. This approach is particularly relevant in managing chronic conditions where long-term efficacy and minimal side effects are critical considerations.

In conclusion, 4-Nor-3,5-seco-5 oxo - 17β hydroxyandrostan - 3 - oic Acid (CAS No. 1759 - 35 - 9) represents a significant advancement in steroid chemistry with promising implications for pharmaceutical development. Its complex structure, versatile reactivity, and biological activity make it a valuable tool for researchers seeking to develop novel therapeutics. As our understanding of steroid mechanisms continues to evolve, compounds like this will undoubtedly play a pivotal role in shaping the future of medicine.

• 2304-89-4(3-Oxo-7a,12a-hydroxy-5b-cholanoic Acid)
• 27975-19-5(Isosteviol)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)